Last reviewed · How we verify
CORT118335 Oral
At a glance
| Generic name | CORT118335 Oral |
|---|---|
| Also known as | Treatment A |
| Sponsor | Corcept Therapeutics |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Alanine aminotransferase increased
- Headache
- Aspartate aminotransferase increased
- Diarrhoea
- Nausea
- Fatigue
- Akathisia
- Orthostatic hypotension
- Abdominal distension
- Feeling less euphoric
- Dizziness
- Anaemia
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CORT118335 Oral CI brief — competitive landscape report
- CORT118335 Oral updates RSS · CI watch RSS
- Corcept Therapeutics portfolio CI